Martin Lehr
Founder at CONTEXT THERAPEUTICS INC.
Net worth: 1 M $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Richard Berman | M | 81 |
Context Therapeutics LLC
 Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | 3 years |
| Jennifer Stacey | F | 59 |
Context Therapeutics LLC
Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | 3 years |
| Philip Kantoff | M | 69 |
Context Therapeutics LLC
Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | 6 years |
| Linda West | F | 64 |
Context Therapeutics LLC
Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | 3 years |
| Sohang Chatterjee | M | - |
Praesidia Biotherapeutics, Inc.
 Praesidia Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Praesidia Biotherapeutics, Inc. is a company that specializes in developing drugs using their proprietary Tunable Linker Technology called LESS (Linker Enzyme Substrate System). The company is based in Arlington, MA. This technology helps to maximize the therapeutic potential of drugs. The company was founded by Sohang Chatterjee, Pradip K. Majumder, and Santosh Kesari, with Sohang Chatterjee serving as the CEO since incorporation. | - |
| Felix Kim | M | - |
Context Therapeutics LLC
Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | 9 years |
| Pradip K. Majumder | M | - |
Praesidia Biotherapeutics, Inc.
Praesidia Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Praesidia Biotherapeutics, Inc. is a company that specializes in developing drugs using their proprietary Tunable Linker Technology called LESS (Linker Enzyme Substrate System). The company is based in Arlington, MA. This technology helps to maximize the therapeutic potential of drugs. The company was founded by Sohang Chatterjee, Pradip K. Majumder, and Santosh Kesari, with Sohang Chatterjee serving as the CEO since incorporation. | - |
| Alex Levit | M | 45 | 3 years | |
| Jennifer Minai-Azary | F | 46 | 3 years | |
| Nilda Mesa | F | 64 |
The Trustees of Columbia University in The City of New York
| 16 years |
| Debra Miller | F | - |
CureDuchenne Ventures LLC
 CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures LLC (CureDuchenne Ventures) is a venture capital subsidiary of CureDuchenne, founded in 2014 by Debra Miller. The firm is headquartered in Newport Beach, California. | - |
| Paul Miller | M | - |
CureDuchenne Ventures LLC
CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures LLC (CureDuchenne Ventures) is a venture capital subsidiary of CureDuchenne, founded in 2014 by Debra Miller. The firm is headquartered in Newport Beach, California. | 21 years |
| Evan G. Dick | M | 72 | - | |
| Shawn Titcomb | M | - |
Praesidia Biotherapeutics, Inc.
Praesidia Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Praesidia Biotherapeutics, Inc. is a company that specializes in developing drugs using their proprietary Tunable Linker Technology called LESS (Linker Enzyme Substrate System). The company is based in Arlington, MA. This technology helps to maximize the therapeutic potential of drugs. The company was founded by Sohang Chatterjee, Pradip K. Majumder, and Santosh Kesari, with Sohang Chatterjee serving as the CEO since incorporation. | 3 years |
| Philip R. Johnson | M | - |
University of Pennsylvania
| 19 years |
| Edward Kaye | M | 75 |
CureDuchenne Ventures LLC
CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures LLC (CureDuchenne Ventures) is a venture capital subsidiary of CureDuchenne, founded in 2014 by Debra Miller. The firm is headquartered in Newport Beach, California. | - |
| Priya Marreddy | F | - | 2 years | |
| Kathlene Balisy | F | - |
CureDuchenne Ventures LLC
CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures LLC (CureDuchenne Ventures) is a venture capital subsidiary of CureDuchenne, founded in 2014 by Debra Miller. The firm is headquartered in Newport Beach, California. | - |
| TJ Farnsworth | M | - |
CureDuchenne Ventures LLC
CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures LLC (CureDuchenne Ventures) is a venture capital subsidiary of CureDuchenne, founded in 2014 by Debra Miller. The firm is headquartered in Newport Beach, California. | - |
| Christopher Beck | M | - | 2 years | |
| Patrice Le Melle | F | 65 |
The Trustees of Columbia University in The City of New York
| 16 years |
| Rob Stavis | M | 61 |
University of Pennsylvania
| 20 years |
| Vera King Farris | M | 87 |
University of Pennsylvania
| 21 years |
| Sullivan Tim | M | - |
CureDuchenne Ventures LLC
CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures LLC (CureDuchenne Ventures) is a venture capital subsidiary of CureDuchenne, founded in 2014 by Debra Miller. The firm is headquartered in Newport Beach, California. | - |
| Bradley Hodges | M | - |
CureDuchenne Ventures LLC
CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures LLC (CureDuchenne Ventures) is a venture capital subsidiary of CureDuchenne, founded in 2014 by Debra Miller. The firm is headquartered in Newport Beach, California. | 2 years |
| John W. Ripple | M | - |
Praesidia Biotherapeutics, Inc.
Praesidia Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Praesidia Biotherapeutics, Inc. is a company that specializes in developing drugs using their proprietary Tunable Linker Technology called LESS (Linker Enzyme Substrate System). The company is based in Arlington, MA. This technology helps to maximize the therapeutic potential of drugs. The company was founded by Sohang Chatterjee, Pradip K. Majumder, and Santosh Kesari, with Sohang Chatterjee serving as the CEO since incorporation. | - |
| Siddhartha Mukherjee | M | - |
The Trustees of Columbia University in The City of New York
| 15 years |
| Ami Miron | M | - |
The Trustees of Columbia University in The City of New York
| 15 years |
| Lianna Orlando | M | - |
CureDuchenne Ventures LLC
CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures LLC (CureDuchenne Ventures) is a venture capital subsidiary of CureDuchenne, founded in 2014 by Debra Miller. The firm is headquartered in Newport Beach, California. | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Alistair James Meadows | M | - |
The Trustees of Columbia University in The City of New York
University of Pennsylvania
| 9 years |
| Kareem Elsirafy | M | - |
The Trustees of Columbia University in The City of New York
| 8 years |
| Tai San Noah Lim | M | 49 |
University of Pennsylvania
| 3 years |
| Qiong Hai | F | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Jonathan Greenbaum | M | - |
The Trustees of Columbia University in The City of New York
University of Pennsylvania
| 6 years |
| César Orosco | M | - |
University of Pennsylvania
| 6 years |
| Anish Monga | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Carol R. Scheman | F | - |
University of Pennsylvania
| 11 years |
| Genna B. Sankin | F | - |
The Trustees of Columbia University in The City of New York
| 3 years |
| Renzo Merino | M | - |
The Trustees of Columbia University in The City of New York
University of Pennsylvania
| 5 years |
| Ragan Robertson | M | - |
The Trustees of Columbia University in The City of New York
| 3 years |
| Ari Levine | M | 41 |
University of Pennsylvania
| 4 years |
| Harini Chundu | F | - |
The Trustees of Columbia University in The City of New York
University of Pennsylvania
| 7 years |
| Stacy Nemeroff | F | - |
University of Pennsylvania
| 3 years |
| Sankesh Abbhi | M | 38 |
The Trustees of Columbia University in The City of New York
| 3 years |
| Amrom Obstfeld | M | - |
The Trustees of Columbia University in The City of New York
University of Pennsylvania
| 8 years |
| Dario Constantine | M | - |
The Trustees of Columbia University in The City of New York
| 5 years |
| Jacob Ma-Weaver | M | 37 |
The Trustees of Columbia University in The City of New York
| 4 years |
| Yang Li | M | 41 |
The Trustees of Columbia University in The City of New York
| 3 years |
| Holger Boerner | M | - |
University of Pennsylvania
| 2 years |
| Jay Cecil | M | - |
University of Pennsylvania
| 2 years |
| Puja Dhanraj | F | - |
University of Pennsylvania
| 5 years |
| Gerson R. Guzman | M | - |
University of Pennsylvania
| 2 years |
| Michael Buchman | M | - |
University of Pennsylvania
| 2 years |
| Siddarth Subramony | M | 37 |
The Trustees of Columbia University in The City of New York
| 5 years |
| Jared Lazarus | M | - |
University of Pennsylvania
| 3 years |
| Ravi Patna | M | - |
University of Pennsylvania
| 4 years |
| Brian S. Goldstein | M | - |
University of Pennsylvania
| 4 years |
| Barbara Morgan | M | - |
University of Pennsylvania
| 5 years |
| Thais Aleluia | F | - |
University of Pennsylvania
| 2 years |
| Vikas Khurana | M | - |
University of Pennsylvania
| 2 years |
| Matthew W. Nugent | M | - |
University of Pennsylvania
| 4 years |
| Ryan Joseph Jack | M | - |
University of Pennsylvania
| 2 years |
| Rajeev Chanderraj | M | - |
University of Pennsylvania
| 4 years |
| Seth Demain | M | - |
University of Pennsylvania
| 2 years |
| James Dunning | M | - |
University of Pennsylvania
| 4 years |
| Sang-Cheol Shin | M | 54 |
University of Pennsylvania
| 2 years |
| Heather Innes | F | - |
University of Pennsylvania
| 4 years |
| Atish Davda | M | - |
University of Pennsylvania
| 4 years |
| Terence Huang | M | - |
University of Pennsylvania
| 4 years |
| Douglas L. Wooden | M | - |
University of Pennsylvania
| 4 years |
| Stefano Rizzi | M | - |
University of Pennsylvania
| 2 years |
| Stephen Shulstein | M | - |
University of Pennsylvania
| 4 years |
| Jerry Kochanski | M | - |
University of Pennsylvania
| 2 years |
| Eleanor Hsu | F | - |
University of Pennsylvania
| 2 years |
| Stuart A. Weiss | M | - |
University of Pennsylvania
| 3 years |
| Ed W. Martin | M | - |
University of Pennsylvania
| 4 years |
| Badal Pandhi | M | - |
University of Pennsylvania
| 4 years |
| Sam Margolin | M | - |
University of Pennsylvania
| 4 years |
| Bo Hunt | M | - |
University of Pennsylvania
| 4 years |
| Brandon S. Verblow | M | - |
University of Pennsylvania
| 4 years |
| Joseph A. Krigsfeld | M | - |
University of Pennsylvania
| 4 years |
| Beeneet Kothari | M | - |
University of Pennsylvania
| 4 years |
| Anna Haskell | F | - |
University of Pennsylvania
| 2 years |
| Hobey Stuart | M | - |
University of Pennsylvania
| 4 years |
| Jim Wiant | M | - |
University of Pennsylvania
| 2 years |
| Jordan Straff | M | - |
University of Pennsylvania
| 4 years |
| Faiza Alwy | F | - |
University of Pennsylvania
| 2 years |
| Andrew C. Chung | M | - |
University of Pennsylvania
| 4 years |
| Sean M. Dervrich | M | - |
University of Pennsylvania
| 4 years |
| Rahul Sondhi | M | - |
University of Pennsylvania
| 2 years |
| David M. Poss | M | - |
University of Pennsylvania
| 4 years |
| Ian Andrew Foster | M | - |
University of Pennsylvania
| 4 years |
| Tom Fang | M | - |
University of Pennsylvania
| 4 years |
| Daniel Spelman | M | - |
University of Pennsylvania
| 4 years |
| John W. Glomb | M | - |
University of Pennsylvania
| 12 years |
| Joseph Paul Weiler | M | - |
University of Pennsylvania
| 4 years |
| Ashish B. Doshi | M | - |
University of Pennsylvania
| 4 years |
| Zach Barasz | M | - |
University of Pennsylvania
| 4 years |
| Clayton Rose | M | 65 |
University of Pennsylvania
| 3 years |
| Jonathan Demchick | M | - |
University of Pennsylvania
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Martin Lehr
- Personal Network
